ASPIRE Award: TBXT and Beyond: Expanding the Chordoma Surfaceome supports researchers studying TBXT and other tumor-specific surface targets to enable surface-targeted therapies for chordoma.
ASPIRE Awards support cancer researchers pursuing high-risk feasibility and proof-of-concept studies to address challenging questions and advance innovative ideas from basic science to early clinical research.
Impact Grant - Chordoma Foundation supports researchers pursuing preclinical and translational chordoma immunology projects to explore new immunotherapy approaches and accelerate research in this disease.
Clinical Innovator Award supports researchers conducting early-phase immunotherapy trials in chordoma, funding clinical investigation to move promising concepts toward potential patient impact.
Accelerator Awards support investigators pursuing ambitious four-year neuroendocrine cancer research to advance early detection, develop new therapies, and match treatments to individual tumor biology.
CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.